Partner Content Partner Content Less than 3 weeks to SMi's 3rd Annual Drug Discovery Chemist... 3 weeks to SMi's 3rd Annual Drug Discovery Chemistry
Partner Content Partner Content Exclusive insights into the latest innovations at Drug Disco... Exclusive insights into the latest innovations
Partner Content Partner Content New Speakers from Roche & Imperial College announced for... Roche to join ADMET conference this July in London
Partner Content Partner Content Dr. Eric Blomme, AbbVie, Chair Invite & Interview Snippet fo... Dr. Eric Blomme, AbbVie, Chair Invite & Interview Snipp
News Chiesi signs $1.9bn deal to buy KalVista and its HAE drug Chiesi has boosted its rare disease business with an agreement to buy KalVista and Ekterly, its oral drug for treating attacks in rare disease HAE.
Sales & Marketing Sponsored Using AI-driven synthetic personas to take your insights fur... As AI continues to reshape the healthcare landscape, pharma teams are beginning to leverage synthetic personas.
